| Literature DB >> 32971623 |
Divya Agarwal1, Rohan Chawla1, Toshit Varshney1, Nawazish Shaikh1, Parijat Chandra1, Atul Kumar1.
Abstract
PURPOSE: The study aims to describe the clinical and demographic profile of patients who required vitreoretinal surgeries during the novel coronavirus disease-2019 (COVID-19) lockdown in India. It also reports our operating protocols and initial experience while performing vitreoretinal surgeries during COVID-19 times at a government tertiary eye care hospital.Entities:
Keywords: COVID-19; COVID-19 lockdown India; Coronavirus; SARS CoV-2; ophthalmology; retinal surgeries
Mesh:
Year: 2020 PMID: 32971623 PMCID: PMC7727968 DOI: 10.4103/ijo.IJO_2140_20
Source DB: PubMed Journal: Indian J Ophthalmol ISSN: 0301-4738 Impact factor: 1.848
Figure 1(a) Ophthalmologist doing retinal examination wearing PPE including face-shield (customized slots for accommodating eyepieces of indirect ophthalmoscope). (b) Retinal surgeon doing vitrectomy using “heads-up” 3D visualization system, wearing PPE and taking standard COVID-19 precautions
Baseline characteristics of patients who were evaluated for vitreoretinal surgery
| Parameter | Baseline characteristics ( |
|---|---|
| Age (Mean±SD*, Range) | 38.4±20.1 years (1 month- 75 years) |
| Gender (%) | |
| Male | 57 (66.3%) |
| Female | 29 (33.7%) |
| Systemic Comorbidities (%) | 39 (45.3%) |
| Diabetes | 25 (29.1%) |
| Hypertension | 26 (30.2%) |
| Cardiovascular disease | 4 (4.6%) |
| Obesity | 2 (2.3%) |
| Cerebrovascular disease | 3 (3.5%) |
| Chronic Kidney Disease | 3 (3.5%) |
| Asthma | 4 (4.6%) |
| Prematurity related co-morbidities | 3 (3.5%) |
| High-risk history on initial triaging (symptoms, contact with COVID-19 positive patients) (%) | 16 (18.6%) |
| States in which patients were residing (%) | |
| Delhi | 46 |
| Haryana | 13 |
| UP | 20 |
| Rajasthan | 3 |
| MP | 1 |
| Assam | 1 |
| Bihar | 1 |
| Jharkhand | 1 |
*SD - Standard deviation
Characteristics of patients who finally underwent vitreoretinal surgery
| Indication of vitreoretinal surgery | Anesthesia required (GA/LA) | No. of patients operated ( | No. of patients requiring re-surgery | Mean age of patients±SD* (years) | No. of males | No. of patients having Systemic co-morbidities | No. of patient who came from Hotspot areas | Fellow eye treatment needed |
|---|---|---|---|---|---|---|---|---|
| Acute Retinal Detachment | LA | 25 (30.1%) | 3 | 41.9±17.2 | 16 | 9 | 18 | 7 |
| GA | 7 (8.4%) | 0 | 12±3.4 | 6 | 1 | 5 | 4 | |
| ROP surgery | GA | 3 (3.6%) | 0 | 0.1±0.05 | 3 | 3 | 2 | 3 |
| Retinal detachment (>4 weeks) | LA | 16 (19.3%) | 0 | 37.7±14.8 | 11 | 4 | 10 | 3 |
| GA | 1 (1.2%) | 0 | 11 | 1 | 0 | 0 | 0 | |
| Acute endophthalmitis (Trauma-related) | LA | 6 (7.2%) | 0 | 63.7±7.8 | 1 | 2 | 5 | 0 |
| GA | 4 (4.8) | 0 | 10.5±1.7 | 3 | 0 | 0 | 0 | |
| Diabetic vitreous hemorrhage with posterior pole TRD/TRD involving macula | LA | 17 (20.5%) | 1 | 49.1±8.8 | 11 | 17 | 13 | 5 |
| Diabetic dense vitreous hemorrhage | LA | 2 (2.4%) | 0 | 66.5±10.6 | 2 | 2 | 0 | 2 |
| Silicone oil removal (high IOP, severe emulsification) | LA | 2 (2.4%) | 0 | 35±11.3 | 1 | 0 | 0 | 0 |
*SD: Standard deviation